Concepedia

Vivian H. Shih

VH

10

Publications

994

Citations

10

H-Index

2011

Active since

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (Sweden)

Temple University

Harvard University

University of Manchester

Vivian H. Shih is an author at AstraZeneca (United States) specializing in medicine, clinical trials, and immunology.

ORCID

Top concepts

Publications per year

2011–2024

10

Publications

10

Benralizumab for the Prevention of COPD Exacerbations

Gerard J. Criner, Bartolomé R. Celli, Christopher E. Brightling et al. · New England Journal of Medicine · 2019 · 311 citations · Full text

Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial

Claus Bachert, Joseph K. Han, Martin Y. Desrosiers et al. · Journal of Allergy and Clinical Immunology · 2021 · 282 citations · Full text

, , +10

Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies

Gerard J. Criner, Bartolomé R. Celli, Dave Singh et al. · The Lancet Respiratory Medicine · 2019 · 110 citations · Full text

, , +5

The impact of neurocognitive impairment on occupational recovery of clinically stable patients with bipolar disorder: a prospective study

Carrie E. Bearden, Vivian H. Shih, Michael F. Green et al. · Bipolar Disorders · 2011 · 104 citations

Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme

David J. Jackson, Girolamo Pelaia, Benjamin Emmanuel et al. · European Respiratory Journal · 2024 · 50 citations · Full text

Rows per page

1–5 of 10